Botulinum neurotoxin and chronic migraine: muscle fiber chemodenervation or nociceptic system modulation?
The results of controlled investigations suggest that botulinumtoxin type A (BTA) leads to decrease headache intensity and prevent migraine attacks. The antinociceptive mechanisms of BTA action remain unclear. Modern and previous hypothesis of antinociceptive action BTA in chronic migraine (CM) are...
Main Authors: | A. R. Artemenko, A. L. Kurenkov, S. S. Nikitin, K. B. Belomestova |
---|---|
Format: | Article |
Language: | Russian |
Published: |
ABV-press
2015-02-01
|
Series: | Nervno-Myšečnye Bolezni |
Subjects: | |
Online Access: | https://nmb.abvpress.ru/jour/article/view/61 |
Similar Items
-
Ultrasound Guidance for Botulinum Neurotoxin Chemodenervation Procedures
by: Katharine E. Alter, et al.
Published: (2017-12-01) -
Ergonomic Recommendations in Ultrasound-Guided Botulinum Neurotoxin Chemodenervation for Spasticity: An International Expert Group Opinion
by: Philippe Lagnau, et al.
Published: (2021-03-01) -
Chemodenervation of the Larynx
by: Rachel Kaye, et al.
Published: (2017-11-01) -
Participation of cannabinoid receptors in peripheral nociception induced by some NSAIDs
by: L.C.R. Silva, et al.
Published: (2012-12-01) -
Participation of cannabinoid receptors in peripheral nociception induced by some NSAIDs
by: L.C.R. Silva, et al.
Published: (2012-12-01)